Stockreport

Shattuck (STTK) Announces Positive Interim Data on Cancer Drug [Yahoo! Finance]

Shattuck Labs, Inc.  (STTK) 
PDF azacitidine, in frontline higher-risk myelodysplastic syndromes (HR-MDS) and TP53 mutant (TP53m) acute myeloid leukemia (AML) patients. SL-172154 is an investigational [Read more]